Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis. (Q54774748)

3 June 2018

title

Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis. (English)

1 reference

3 June 2018

0 references

0 references

Bergeron MG

1

1 reference

3 June 2018

Marois Y

series ordinal

2

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 October 1986

1 reference

3 June 2018

published in

Kidney International

1 reference

3 June 2018

volume

30

1 reference

3 June 2018

issue

4

1 reference

3 June 2018

page(s)

481-487

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1038/ki.1986.211

exact match

0 references

cites work

Renal parenchymal accumulation of aminoglycoside antibiotics in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Influence of Single or Multiple Doses of Gentamicin and Netilmicin on Their Cortical, Medullary, and Papillary Distribution

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Pharmacokinetics of gentamicin in the treatment of renal infection: A therapeutic anomaly explained

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Intrarenal concentrations of ampicillin in acute pyelonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Significance of intrarenal concentrations of gentamicin for the outcome of experimental pyelonephritis in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Synergism of Ampicillin and Gentamicin against Obstructive Pyelonephritis Due to Escherichia coli in Rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

The effect of water diuresis on spread of bacteria through the urinary tract

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Intrarenal distribution of trimethoprim and sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Hematogenous pyelonephritis in rats. I. Its pathogenesis when produced by a simple new method

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Experimental pyelonephritis. I. Effect of ureteral ligation on the course of bacterial infection in the kidney of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Treatment of Experimental Ascending <i>Escherichia coli</i> Pyelonephritis with Ceftriaxone Alone and in Combination with Gentamicin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Intrarenal antibiotic distribution in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Prevention of Pyelonephritis Due to Escherichia coli in Rats with Gentamicin Stored in Kidney Tissue

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

THE LOCALIZATION AND TREATMENT OF URINARY TRACT INFECTIONS: THE ROLE OF BACTERICIDAL URINE LEVELS AS OPPOSED TO SERUM LEVELS

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Influence of water diuresis on antimicrobial treatment of enterococcal pyelonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Interaction of purulent material with antibiotics used to treat Pseudomonas infections

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Binding of antibiotics to tissue homogenates.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Inhibition of the Antibacterial Activity of Gentamicin by Urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Comparative pharmacokinetics and metabolism of cephapirin in laboratory animals and humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

"Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Increased nephrotoxicity of gentamicin in pyelonephritic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1986.211

7 January 2021

Identifiers

DOI

10.1038/KI.1986.211

1 reference

3 June 2018

PubMed ID

3537452

1 reference

3 June 2018